Next Generation Sequencing (NGS) can be called a true “fusion technology”. By combining applied biochemistry, physical chemistry, biophysics, materials sciences, nanoscience, mathematics and complex system informatics life sciences has been pushed into a new era of exploring the miracle of life.
Since introduction of “Sanger Sequencing” one thing remained to be an integral part of any used technology platform throughout the evolution of decoding genomes: synthetic oligonucleotides
Hence, supplies of oligonucleotides have been and are of the essence for enjoying the full potential of technological development. Ensuring “full bloom” is based on two major aspects:
- Quality of the input material, i. e. quality of the oligonucleotides in order to achieve
best technical and scientific performance.
- Affordability of the input material, i. e. price-quality ratio of the oligonucleotides in
order to achieve best economic efficiency.
This is where metabion comes in! For more than ten years we have been and are dedicated to enhance blooming of biotechnological progress by supporting advanced platforms that require high quality oligonucleotides at economic scales.
With the introduction of 454 Sequencing™ a NGS benchmark has been set by Roche Applied Sciences through its center of excellence - 454 Life Sciences™. GS FLX and GS Junior systems are highly advanced platforms enabling de novo sequencing and re-sequencing of genomes, targeted sequencing of DNA regions of interest, high-resolution typing, metagenomic sequence-, and RNA-analysis.
metabion now offers nGS FusionPrimers, and nGS Adaptor A and B oligonucleotides at lived metabion top quality for best performance of your 454 Sequencing™ application.
In order to satisfy your needs for best cost effectiveness, we have carefully developed proprietary production protocols and expertise allowing us to present you with an attractive portfolio and pricing scheme.